“吃药喝酒行情蓄势待发”!资金抢筹生物医药ETF(159859)1亿份,食品饮料ETF天弘(159736)“六吸金”

格隆汇
Sep 09

今日前期强势的AI硬件板块全线回调,食品饮料ETF天弘(159736)探底回升,盘中获资金净申购2200万份额,生物医药ETF(159859)盘中更是被大幅净申购1.04亿份。 事实上,食品饮料ETF天弘(159736,联接C:001632)近期强势“吸金”,算上今日盘中净申购,连续六日迎来资金净流入,近20个交易日有16日“吸金”,规模超2.7亿,背后或是: ①资金瞄准国庆+中秋双节带来的消费需求。 ②贵州茅台60亿回购刚收官,8月29日再官宣控股股东再掷逾30亿增持。 ③商务部:下个月将出台扩大服务消费若干政策措施 生物医药ETF(159859,联接C:011041):聚焦生物医药全产业链,涵盖创新药、医疗器械、医疗服务等细分领域,成分股兼具研发实力与成长潜力,契合医药产业创新升级趋势,消息面上: ①恒瑞医药签署HRS-1893项目授权许可协议,总金额最高有望超10亿美元 ②9月6日-9日,国际肺癌研究学会举办的2025年世界肺癌大会在西班牙巴塞罗那举行 ③9月2日,ArrowheadPharmaceuticals宣布与诺华公司就临床前阶段帕金森方向siRNA疗法ARO-SNCA达成交易。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10